Search - tctmd.com

Displaying 41 - 60 of 84

Sort: Relevancy | Date

Ischemic Strokes More Severe, Deadlier in COVID-19

News Daily News

Ischemic Strokes More Severe, Deadlier in COVID-19

July 14, 2020

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

News Daily News

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Michael O'Riordan

July 13, 2020

‘Relatively Low’ Stroke Incidence in COVID-19, but More Are Cryptogenic

News Daily News

‘Relatively Low’ Stroke Incidence in COVID-19, but More Are Cryptogenic

Yael L. Maxwell

May 25, 2020

COVID-19 in NYC: CV Risk Factors and Bleak Outcomes in the Critically Ill

News Daily News

COVID-19 in NYC: CV Risk Factors and Bleak Outcomes in the Critically Ill

Michael O'Riordan

May 19, 2020

Stroke ‘Surge’ in the Young Fuels Debate Over COVID-19’s Culpability

News Features

Stroke ‘Surge’ in the Young Fuels Debate Over COVID-19’s Culpability

May 08, 2020

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

News Daily News

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Michael O'Riordan

March 11, 2020

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

News Conference News CRT 2020

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

Michael O'Riordan

February 26, 2020

Rivaroxaban Falls Flat in Antiphospholipid Antibody Syndrome

News Daily News

Rivaroxaban Falls Flat in Antiphospholipid Antibody Syndrome

October 15, 2019

PFO Compounds Ischemic Stroke Risk Among Patients With Pulmonary Embolism

News Daily News

PFO Compounds Ischemic Stroke Risk Among Patients With Pulmonary Embolism

Yael L. Maxwell

May 06, 2019

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

News Daily News

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

February 26, 2019

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

News Daily News

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

January 10, 2019

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

News Conference News AHA 2018

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

November 11, 2018

Dabigatran Trials Come Up Short for Stroke of Unknown Cause and Cerebral Venous Thrombosis

News Daily News

Dabigatran Trials Come Up Short for Stroke of Unknown Cause and Cerebral Venous Thrombosis

October 26, 2018

Novel LAA Closure Device Shows Promise in Early Experience

News Conference News TCT 2018

Novel LAA Closure Device Shows Promise in Early Experience

September 22, 2018

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

Platelet Reactivity Linked With Ischemic Stroke Risk Post-DES Implantation: ADAPT-DES Substudy

News Daily News

Platelet Reactivity Linked With Ischemic Stroke Risk Post-DES Implantation: ADAPT-DES Substudy

Yael L. Maxwell

June 08, 2018

WISE LE Data Build the Case for Embolic Protection in Lower-Extremity Atherectomy

News Conference News ISET 2018

WISE LE Data Build the Case for Embolic Protection in Lower-Extremity Atherectomy

February 13, 2018

Research Series Sheds Light on Questions Surrounding Stroke Risk in Women

News Daily News

Research Series Sheds Light on Questions Surrounding Stroke Risk in Women

February 09, 2018

Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients

News Conference News VIVA 2017

Apixaban May Be Better Choice Than Rivaroxaban for DVT Patients

September 11, 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

News Conference News ACC 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Michael O'Riordan

March 19, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.